The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide.

Daneau, Géraldine; Gumusboga, Mourad; De Rijk, Pim; Trebucq, Arnaud; Rigouts, Leen; Van Deun, Armand; de Jong, Bouke C

Daneau, Géraldine; Gumusboga, Mourad; De Rijk, Pim; Trebucq, Arnaud; Rigouts, Leen; Van Deun, Armand; de Jong, Bouke C.

Affiliation

Daneau G; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. Electronic address: gdaneau@itg.be.
Gumusboga M; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
De Rijk P; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Trebucq A; International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
Rigouts L; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. Electronic address: lrigouts@itg.be.
Van Deun A; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
de Jong BC; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Int J Mycobacteriol ; 5 Suppl 1: S46-S47, 2016 Dec.

Article de En | MEDLINE | ID: mdl-28043604

Mots clés

MDR-TB; Mutation; Pyrazinamide (PZA); Resistance; Tuberculosis; pncA

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Int J Mycobacteriol Année: 2016 Type de document: Article Pays de publication: Inde

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google